Jan Fagius

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family

Fagius, Jan; Klar, Joakim; Dahl, Niklas

Ingår i Clinical Autonomic Research, s. 421-432, 2023

• DOI för Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family
• Ladda ner fulltext (pdf) av Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family

Hemisfärernas musik – ur barnets perspektiv: Barn kan och vill sjunga

Fagius, Jan; Fagius, Gunnel

Ingår i Socialmedicinsk Tidskrift, s. 684-696, 2022

Den neurologiska konsultationen

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Neurologisk symtomlära

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family

Fagius, Jan; Klar, Joakim; Dahl, Niklas

Ingår i Clinical Autonomic Research, s. 421-432, 2023

• DOI för Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family
• Ladda ner fulltext (pdf) av Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family

Hemisfärernas musik – ur barnets perspektiv: Barn kan och vill sjunga

Fagius, Jan; Fagius, Gunnel

Ingår i Socialmedicinsk Tidskrift, s. 684-696, 2022

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Tolf, Andreas; Fagius, Jan; Carlson, Kristina; Åkerfeldt, Torbjörn et al.

Ingår i Acta Neurologica Scandinavica, s. 320-327, 2019

• DOI för Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Short-term prediction of secondary progression in a slinding window: A test of a prdicting alogrithm in a validation cohort

Skoog, Bengt; Link, Jenny; Tedeholm, Helen; Longfils, Marco et al.

Ingår i Multiple Sclerosis Journal, Experimental, Translational and Clinical, s. 1-10, 2019

• DOI för Short-term prediction of secondary progression in a slinding window: A test of a prdicting alogrithm in a validation cohort
• Ladda ner fulltext (pdf) av Short-term prediction of secondary progression in a slinding window: A test of a prdicting alogrithm in a validation cohort

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Burt, Richard K.; Balabanov, Roumen; Burman, Joachim; Sharrack, Basil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 165-174, 2019

• DOI för Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Corpus callosum atrophy in MS is halted by autologous haematopoietic stem cell transplantation

Tolf, Andreas; Granberg, T.; Larsson, Elna-Marie; Landtblom, Anne-Marie et al.

Ingår i Multiple Sclerosis Journal, s. 1006-1007, 2017

Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients: First line drugs vs natalizumab

Fagius, Jan; Feresiadou, Amalia; Larsson, Elna-Marie; Burman, Joachim

Ingår i Multiple Sclerosis and Related Disorders, s. 82-87, 2017

• DOI för Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients: First line drugs vs natalizumab

Severe relapses and rebound activity after natalizumab discontinuation in MS patients with more than five years of treatment with stable disease course

Fagius, Jan; Burman, Joachim; Feresiadou, Amalia; Larsson, Elna-Marie

Ingår i Multiple Sclerosis Journal, s. 297-297, 2015

Assessing tissue damage in multiple sclerosis: a biomarker approach

Burman, Joachim; Zetterberg, H; Fransson, Moa; Loskog, Angelica SI. et al.

Ingår i Acta Neurologica Scandinavica, s. 81-89, 2014

• DOI för Assessing tissue damage in multiple sclerosis: a biomarker approach

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Burman, Joachim; Iacobaeus, Ellen; Svenningsson, Anders; Lycke, Jan et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 1116-1121, 2014

• DOI för Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Normal outcome of pregnancy with ongoing treatment with natalizumab

Fagius, Jan; Burman, Joachim

Ingår i Acta Neurologica Scandinavica, 2014

• DOI för Normal outcome of pregnancy with ongoing treatment with natalizumab

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Burman, Joachim; Svensson, Emma; Fransson, Moa; Loskog, Angelica S I et al.

Ingår i Journal of Neuroimmunology, s. 153-159, 2014

• DOI för The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

Tedeholm, H; Lycke, J; Skoog, B; Lisovskaja, V et al.

Ingår i Multiple Sclerosis Journal, s. 765-774, 2013

• DOI för Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs
• Ladda ner fulltext (pdf) av Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

The immunomodulation and multiple sclerosis epidemiology (IMSE) study; a Swedish nationwide pharmaco-epidemiological and genetic study focussed on long-term safety and efficacy of natalizumab (Tysabri)

Jonsson, L.; Piehl, F.; Hillert, J.; Nilsson, P. et al.

Ingår i Multiple Sclerosis Journal, s. 205-205, 2013

The immunomodulation and multiple sclerosis epidemiology (IMSE II) study: a Swedish nationwide pharmaco-epidemiological and genetic study focussed on long-term safety and efficacy of fingolimod (Gilenya (R))

Nordin, N.; Hillert, J.; Piehl, F.; Svenningsson, A. et al.

Ingår i Multiple Sclerosis Journal, s. 445-446, 2013

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

Burman, Joachim; Fransson, Moa; Tötterman, Thomas H.; Fagius, Jan et al.

Ingår i Immunology, s. 211-219, 2013

• DOI för T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

The 'Immunomodulation and Multiple Sclerosis Epidemiology' (IMSE) study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of natalizumab (Tysabri)

Holmen, C.; Piehl, F.; Hillert, J.; Nilsson, P. et al.

Ingår i European Journal of Neurology, s. 751-751, 2012

High resting level and weak response of baroreflex-governed sympathetic outflow in amyotrophic lateral sclerosis

Nygren, Ingela; Fagius, Jan

Ingår i Muscle and Nerve, s. 432-440, 2011

• DOI för High resting level and weak response of baroreflex-governed sympathetic outflow in amyotrophic lateral sclerosis

Bilateral and recurrent optic neuritis in multiple sclerosis

Burman, Joachim; Raininko, Raili; Fagius, Jan

Ingår i Acta Neurologica Scandinavica, s. 207-210, 2011

• DOI för Bilateral and recurrent optic neuritis in multiple sclerosis

Strong potential for baroreflex-governed sympathetic outflow revealed during nausea

Fagius, Jan; Nygren, Ingela

Ingår i Clinical Autonomic Research, s. 371-374, 2010

• DOI för Strong potential for baroreflex-governed sympathetic outflow revealed during nausea

T regulatory cells lacking CD25 are increased in MS during relapse

Fransson, Moa; Burman, Joachim; Lindqvist, Camilla; Atterby, Christina et al.

Ingår i Autoimmunity, s. 590-597, 2010

• DOI för T regulatory cells lacking CD25 are increased in MS during relapse

Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation

Fagius, Jan; Lundgren, J.; Öberg, Gunnar

Ingår i Multiple Sclerosis Journal, s. 229-237, 2009

• DOI för Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation

The T-cell pool is anergized in patients with multiple sclerosis in remission

Fransson, Moa; Liljenfeldt, Lina S.; Fagius, Jan; Tötterman, Thomas et al.

Ingår i Immunology, s. 92-101, 2009

• DOI för The T-cell pool is anergized in patients with multiple sclerosis in remission

Blodstamcellstransplantation vid MS. Motiverat och i så fall när?

Fagius, Jan; Öberg, Gunnar

Ingår i Läkartidningen, s. 640-642, 2006

Ingen grund för kritiken

Hårdemark, Hans-Göran; Persson, Lennart; Fagius, Jan; Aquilonius, Sten-Magnus

Ingår i Läkartidningen, s. 2885, 2005

Neurologi

Fagius, Jan; Nyholm, Dag

Liber, 2012

Neurologi

Fagius, Jan; Aquilonius, Sten-Magnus

Liber AB, Stockholm, 2006

Den neurologiska konsultationen

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Neurologisk symtomlära

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Neurologisk symtomlära

Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2012

Den neurologiska undersökningen

Fagius, Jan; Nyholm, Dag; Aquilonius, Sten-Magnus

Ingår i Neurologi, Liber, 2012

Barnet, hjärnan, musiken och sången

Fagius, Jan; Lagercrantz, Hugo

Ingår i Barn och sång, Studentlitteratur, 2007

Autonoma nervsystemet inklusive sexuella funktioner

Brattberg, Axel; Fagius, Jan

Ingår i Rehabiliteringsmedicin - teori och praktik, Studentlitteratur, 2006

Neurologiska komplikationer till internmedicinska sjukdomar

Ryberg, Björn; Fagius, Jan

Ingår i Neurologi, s. 568, Liber AB, Stockholm, 2006

Autonom dysfunktion

Fagius, Jan

Ingår i Neurologi, s. 568, Liber AB, Stockholm, 2006

Synpunkter på åldrandets neurologi

Fagius, Jan

Ingår i Neurologi, s. 568, Liber AB, Stockholm, 2006

Akutneurologi

Danfors, Torsten; Fagius, Ja

Ingår i Neurologi, s. 568, Liber AB, Stockholm, 2006

Perifera nervskador

Fagius, Jan

s. 568, Liber AB, Stockholm, 2006

Ryggmärgens sjukdomar

Fagius, Jan

Ingår i Neurologi, s. 568, Liber AB, Stockholm, 2006

Den neurologiska undersökningen

Aquilonius, Sten-Magnus; Fagius, Jan

Ingår i Neurologi, s. 568, Liber AB Stockholm, 2006

Neurologisk symtomlära

Fagius, Jan; Aquilonius, Sten-Magnus

Ingår i Neurologi, s. 568, Liber AB, 2006

Cerebral blood flow in multiple sclerosis: an ¹⁵O-water PET study

Tolf, Andreas; Hedman, Karolina; Appel, Lieuwe; Larsson, Elna-Marie et al.